AcuNetx (ANTX) Stock Research, Analysis & News

Quick Analysis on AcuNetx (ANTX) Stock as of February 20, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about AcuNetx (ANTX) Stock below)

AcuNetx (ANTX) Stock Profile Summary

AcuNetx, Inc., together with its subsidiaries, engages in the design, manufacture, and marketing of diagnostic, analytical, and therapeutic devices to the health providers, law enforcement officers, and employers in high-risk industries in the United States. The company offers neurological diagnostic equipment that measures, tracks, and records human eye movements utilizing its proprietary technology and computer software as a method to diagnose problems of the vestibular (balance) system and other balance disorders. It also provides devices designed to test individuals for impaired performance resulting from the influences of alcohol, drugs, illness, stress, and other factors that affect eye and pupil performance. In addition, the company offers orthopedic and cranio-maxillofacial surgery products, which generate new bone through the process of distraction osteogenesis. Further, the company provides SmartDevice-Connect that establishes product registry to individual patients and tracks device behavior for post-market surveillance, adverse event, and outcomes reporting, as well as the creation of smart devices that gather and transmit physiological data concerning the device and its interaction with patients. Additionally, it provides repair and maintenance, consulting, and education services to its customers. AcuNetx offers its products through manufacturer representatives, international dealers, and private label distributors, as well as through direct sales force. The company is headquartered in Torrance, California.

AcuNetx (ANTX) Stock Key Statistics Research and Analysis as of February 20, 2020

Mutual Funds with AcuNetx (ANTX) Stock in its top 10 holdings

FundCategoryANTX Holding Percentage
AllianzGI Convertible PConvertibles1.99%
AllianzGI Convertible AdministrativeConvertibles1.99%
AllianzGI Convertible InstitutionalConvertibles1.99%
Calamos Growth & Income IAllocation--50% to 70% Equity1.81%

Latest Market News on AcuNetx (ANTX)

Click here to find the latest news on AcuNetx (ANTX)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center